Form 4 for WGS GeneDx Holdings Corp.
Accepted 2022-01-19 00:00:00 ET · period of report 2022-01-14 · accession 0001209191-22-003867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-19 | 2022-01-14 | WGS | Clark Daniel Emmett | GC, Sec | M - OptEx | $0.15 | +275.0K | 281.4K | +4,303% | +$41.2K |
| D | 2022-01-19 | 2022-01-14 | WGS | Clark Daniel Emmett | GC, Sec | M - OptEx | $0.00 | -275.0K | 839.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-14 | M | A | 275,000 | $0.15 | 281,391 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-01-14 | M | D | 275,000 | $0.00 | 839,504 | D | $0.15 · — to 2027-06-19 | 275,000 Class A Common Stock | (F1) This option is fully vested. |